Comparison of SYK Signaling Networks Reveals the Potential Molecular Determinants of Its Tumor-Promoting and Suppressing Functions
Spleen tyrosine kinase (SYK) can behave as an oncogene or a tumor suppressor, depending on the cell and tissue type. As pharmacological SYK inhibitors are currently evaluated in clinical trials, it is important to gain more information on the molecular mechanisms underpinning these opposite roles. T...
Main Authors: | Marion Buffard, Aurélien Naldi, Gilles Freiss, Marcel Deckert, Ovidiu Radulescu, Peter J. Coopman, Romain M. Larive |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/11/2/308 |
Similar Items
-
Enhancer RNA AL928768.3 from the IGH Locus Regulates MYC Expression and Controls the Proliferation and Chemoresistance of Burkitt Lymphoma Cells with IGH/MYC Translocation
by: Ekaterina Mikhailovna Stasevich, et al.
Published: (2022-04-01) -
Connecting the SYK Dots
by: Dmitri V. Khveshchenko
Published: (2020-06-01) -
Seeking to Develop Global SYK-Ness
by: Dmitri V. Khveshchenko
Published: (2018-11-01) -
Synergistic Anti-Tumour Effect of Syk Inhibitor and Olaparib in Squamous Cell Carcinoma: Roles of Syk in EGFR Signalling and PARP1 Activation
by: Duen-Yi Huang, et al.
Published: (2020-02-01) -
Role of Tyrosine Kinase Syk in Thrombus Stabilisation at High Shear
by: Gina Perrella, et al.
Published: (2022-01-01)